Enzo’s Cucina Reveals Why Italian Cuisine Remains a Top Choice for Events and Functions

Italian cuisine remains among Australia’s most requested menus for group dining, corporate gatherings, and milestone celebrations. Its broad ...
TechRepublic

Project Management Information Systems Explained: Functions, Tools & Examples

Explore how project management information systems guide each project phase, the tools that support them, and real-world use across industries. Project management information systems extend far beyond ...
Investing

Omeros stock rises as first commercial YARTEMLEA shipments begin

Investing.com -- Omeros Corporation (NASDAQ:OMER) stock rose 3.1% on Tuesday after the company announced it has completed its first commercial shipments of YARTEMLEA (narsoplimab-wuug) to distributors ...
Times Argus

Omeros Announces First Commercial Sales of YARTEMLEA®

Omeros Corporation (NASDAQ: OMER) today announced that the first commercial shipments of YARTEMLEA ® (narsoplimab-wuug) to its distributors were completed last week, with orders from transplant ...
Morningstar

Omeros Announces First Commercial Sales of YARTEMLEA®

— Initial Orders Received and Fulfilled from Multiple Transplant Centers, with YARTEMLEA Now Administered to Both Adult and Pediatric Patients with TA-TMA — Omeros Corporation (NASDAQ: OMER) today ...
Geeky Gadgets

Build Faster Excel Workflows Using FILTER, IFS, XLOOKUP, and LET for Real-World Data

What if you could transform hours of tedious spreadsheet work into just minutes of streamlined efficiency? Simon Sez IT takes a closer look at how Excel’s most powerful functions can transform the way ...
Seeking Alpha

FDA Approves Omeros’ YARTEMLEA® – First and Only Therapy Indicated for TA-TMA

SEATTLE--(BUSINESS WIRE)-- Omeros Corporation (OMER) today announced that the U.S. Food and Drug Administration (FDA) has approved YARTEMLEA ® (narsoplimab-wuug) for the treatment of hematopoietic ...
Investing

Omeros stock soars after FDA approves first treatment for TA-TMA

Investing.com -- Omeros Corporation (NASDAQ:OMER) stock surged 61.6% Wednesday after the FDA approved YARTEMLEA, the first and only treatment for hematopoietic stem cell transplant-associated ...
Nasdaq

Omeros Wins FDA Approval For YARTEMLEA In Transplant-Associated Thrombotic Microangiopathy

(RTTNews) - Omeros Corporation (OMER) today announced that the FDA has approved YARTEMLEA for the treatment of hematopoietic stem cell transplant-associated thrombotic microangiopathy in adults and ...
MarketWatch

Omeros Gets FDA Approval of Yartemlea

Omeros has won U.S. Food and Drug Administration approval of its Yartemlea treatment for an often-fatal complication of stem-cell transplants. Omeros on Wednesday said the approval covers Yartemlea ...